|
1
|
Stout AP: Juvenile fibromatoses. Cancer.
7:953–978. 1954. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hosalkar HS, Torbert JT, Fox EJ, Delaney
TF, Aboulafia AJ and Lackman RD: Musculoskeletal desmoid tumors. J
Am Acad Orthop Surg. 16:188–198. 2008.PubMed/NCBI
|
|
3
|
Gurbuz AK, Giardiello FM, Petersen GM, et
al: Desmoid tumours in familial adenomatous polyposis. Gut.
35:377–381. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hartley JE, Church JM, Gupta S, McGannon E
and Fazio VW: Significance of incidental desmoids identified during
surgery for familial adenomatous polyposis. Dis Colon Rectum.
47:334–338. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hallet M: NINDS myotatic reflex scale.
Neurology. 43:27231993. View Article : Google Scholar
|
|
6
|
Tejpar S, Nollet F, Li C, et al:
Predominance of beta-catenin mutations and beta-catenin
dysregulation in sporadic aggressive fibromatosis (desmoid tumor).
Oncogene. 18:6615–6620. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alman BA, Li C, Pajerski ME, Diaz-Cano S
and Wolfe HJ: Increased beta-catenin protein and somatic APC
mutations in sporadic aggressive fibromatoses (desmoid tumors). Am
J Pathol. 151:329–334. 1997.PubMed/NCBI
|
|
8
|
Aberle H, Bauer A, Stappert J, Kispert A
and Kemler R: β-Catenin is a target for the ubiquitin-proteasome
pathway. EMBO J. 16:3797–3804. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rubinfeld B, Albert I, Porfiri E, Fiol C,
Munemitsu S and Polakis P: Binding of GSK3β to the APC-β-catenin
complex and regulation of complex assembly. Science. 272:1023–1026.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ghanbari-Azarnier R, Sato S, Wei Q,
Al-Jazrawe M and Alman BA: Targeting stem cell behavior in desmoid
tumors (aggressive fibromatosis) by inhibiting hedgehog signaling.
Neoplasia. 15:712–719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu C, Nik-Amini S, Nadesan P, Stanford WL
and Alman BA: Aggressive fibromatosis (desmoid tumor) is derived
from mesenchymal progenitor cells. Cancer Res. 70:7690–7698. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Escobar C, Munker R, Thomas JO, Li BD and
Burton GV: Update on desmoid tumors. Ann Oncol. 23:562–569. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rhim JH, Kim JH, Moon KC, et al: Desmoid
type fibromatosis in the head and neck: CT and MR imaging
characteristics. Neuroradiology. 55:351–359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nishio J, Aoki M, Nabeshima K, Iwasaki H
and Naito M: Imaging features of desmoid-type fibromatosis in the
teres major muscle. In Vivo. 27:555–559. 2013.PubMed/NCBI
|
|
15
|
Owens CL, Sharma R and Ali SZ: Deep
fibromatosis (desmoid tumor): Cytopathologic characteristics,
clinicoradiologic features and immunohistochemical findings on
fine-needle aspiration. Cancer. 111:166–172. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qi H, Cal Cin P, Hernandez JM, et al:
Trisomies 8 and 20 in desmoid tumors. Cancer Genet Cytogenet.
92:147–149. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fiore M, Rimareix F, Mariani L, et al:
Desmoid-type fibromatosis: A front-line conservative approach to
select patients for surgical treatment. Ann Surg Oncol.
16:1587–1593. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bonvalot S, Eldweny H, Haddad V, et al:
Extra-abdominal primary fibromatosis: Aggressive management could
be avoided in a subgroup of patients. Eur J Surg Oncol. 34:462–468.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
van Broekhoven DL, Verhoef C, Elias SG, et
al: Local recurrence after surgery for primary extra-abdominal
desmoid type fibromatosis. Br J Surg. 100:1214–1219. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ballo MT, Zagars GK, Pollack A, Pisters PW
and Pollack RA: Desmoid Tumor: Prognosis factors and outcome after
surgery, radiation therapy, or combined surgery and radiation
therapy. J Clin Oncol. 17:158–167. 1999.PubMed/NCBI
|
|
21
|
Gluck I, Griffith KA, Biermann JS, Feng
FY, Lucas DR and Ben-Josef E: Role of radiotherapy in the
management of desmoid tumors. Int J Radiat Oncol Biol Phys.
80:787–792. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shin SH, Ko KR, Cho SK, Choi YL and Seo
SW: Surgical outcome of desmoid tumors: adjuvant radiotherapy
delayed the recurrence, but did not affect long-term outcomes. J
Surg Oncol. 108:28–33. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Klein WA, Miller HH, Anderson M and
DeCosse JJ: The use of indomethacin, sulindac and tamoxifen for the
treatment of desmoid tumors associated with familial polyposis.
Cancer. 60:2863–2868. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Janinis J, Patriki M, Vini L, Aravantinos
G and Whelan JS: The pharmacological treatment of aggressive
fibromatosis: A systematic review. Ann Oncol. 14:181–190. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Devata S and Chugh R: Desmoid tumors: A
comprehensive review of the evolving biology, unpredictable
behavior and myriad of management options. Hematol Oncol Clin North
Am. 27:989–1005. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sundaram M, Duffrin H, McGuire MH and Vas
W: Synchronous multicentric desmoid tumors (aggressive
fibromatosis) of the extremities. Skeletal Radiol. 17:16–19. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Antal I, Szendroi M, Kovacs G, Nagykalnai
T and Entz L: Multicentric extraabdominal desmoid tumor: a case
report. J Cancer Res Clin Oncol. 120:190–193. 1994. View Article : Google Scholar
|
|
28
|
Watanabe K, Ogura G, Tajino T and Suzuki
T: Extra-abdominal desmoid fibromatosis: Two familial cases with
synchronous and metachronous multicentric hyalinizing nodules.
Histopathology. 41:118–121. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Eccles DM, van der Lujit R, Breukel C, et
al: Hereditary desmoid disease due to a frameshift mutation at
codon 1924 of the APC gene. Am J Hum Genet. 59:1193–201.
1996.PubMed/NCBI
|
